Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery
Clinical trial NCT02169284 · TERMINATED
Trial details
- NCT number
- NCT02169284
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2018-03-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.